Published in

Royal Society of Chemistry, Chemical Communications, 69(55), p. 10214-10217, 2019

DOI: 10.1039/c9cc04145a

Links

Tools

Export citation

Search in Google Scholar

Targeting the Mycobacterium tuberculosis transpeptidase LdtMt2 with cysteine-reactive inhibitors including ebselen

Journal article published in 2019 by Mariska de Munnik, Christopher T. Lohans ORCID, Pauline A. Lang ORCID, Gareth W. Langley, Tika R. Malla, Anthony Tumber, Christopher J. Schofield ORCID, Jürgen Brem ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Inhibitors targeting the conserved nucleophilic cysteine of the mycobacterial l,d-transpeptidases are a potential strategy for the treatment of tuberculosis.